Kraft Davis & Associates’s Eli Lilly LLY Stock Holding History

Kraft Davis & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$497K	Buy	398 +24	+6%	+$28.3K	0.1%	87
2026 Q2	$457K	Buy	374 +17	+5%	+$17.4K	0.1%	94
2026 Q1	$337K	Buy	357 +25	+8%	+$25.3K	0.07%	109
2025 Q4	$357K	Buy	332 +41	+14%	+$39.2K	0.08%	114
2025 Q3	$246K	Sell	291 -43	-13%	-$32K	0.06%	129
2025 Q2	$270K	Buy	334 +41	+14%	+$31.9K	0.07%	119
2025 Q1	$241K	Sell	293 -68	-19%	-$56.6K	0.08%	113
2024 Q4	$315K	Buy	361 +68	+23%	+$56.3K	0.09%	96
2024 Q3	$248K	Hold	293	–	–	0.07%	124
2024 Q2	$236K	Sell	293 -3	-1%	-$2.4K	0.07%	125
2024 Q1	$225K	Buy	+296	New	+$211K	0.07%	125

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Kraft Davis & Associates's LLY Position: Q3 2026 in Review

Kraft Davis & Associates increased its Eli Lilly (LLY) stake by 6.4% in Q3 2026, buying an estimated $28.3K and bringing the position to 398 shares worth $497K. The position accounts for 0.1% of the portfolio, ranked #87.

Kraft Davis & Associates first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Kraft Davis & Associates held 398 shares of Eli Lilly worth $497K as of Q3 2026.
Kraft Davis & Associates bought 24 Eli Lilly shares in Q3 2026, an estimated $28.3K.
Eli Lilly made up 0.1% of Kraft Davis & Associates's portfolio in Q3 2026, its #87 holding.
Kraft Davis & Associates first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kraft Davis & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.